References
- Rhoades HM, Overall JE. The semi-structured BPRS interview and rating guide. Psychopharmacol Bull 1988;24:101–4.
- Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261–76.
- Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiat 1980;137:383–6.
- De Hert M, Wampers M, Thys E, Wieselgren IM, Lindstrom E, Peuskens J. Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability. Int J Psych Clin Pract 2001;6:135–40.
- van der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, . The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res 2006;85:273–9.
- van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, . The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophr Res 2006;85:280–7.
- Levine SZ, Rabinowitz J. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale. J Clin Psychopharmacol 2007;27:431–6.
- von Knorring L, Lindström E. The Swedish version of the positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability. Acta Psychiatr Scand 1992;86:463–8.
- Lindström E, Ekselius L, Jedenius E, Almqvist A, Wieselgren l-M. A checklist for assessment of treatment in schizophrenic syndromes: Interscale validity and interrater reliability. Primary Care Psych 1997;3–4:183–7.
- Kay SR, Opler LA, Fiszbein A, Ramirez P. Positive and Negative Syndrome Scale. Manual. Toronto: Multi-Health System Inc.; 2000.
- Lindström E, Eberhard J, Levander S. Five years follow up during antipsychotic treatment; Efficacy, safety, functional and social outcome. Acta Psychiatr Scand 2007 Suppl 1–14.
- American Psychiatric Association, APA. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th edition. Washington, DC: American Psychiatric Press; 1994.
- Hodgins S, Tengstrom A, Eriksson A, Osterman R, Kronstrand R, Eaves D, . A multisite study of community treatment programs for mentally ill offenders with major mental disorders. Crim Justice Behav 2006;34:211–28.
- Vermundt JK, Magidson J. Latent GOLD 4.0 User's Guide. Belmont, MA: Statistical Innovations Inc.; 2005.
- Leucht S, Davis JM, Engel RR, Kissling W, Kane JM. Definitions of response and remission in schizophrenia: Recommendations for their use and their presentation. Acta Psychiatr Scand Suppl. 2009;438:7–14.
- Eberhard J, Levander S, Lindström E. Remission in schizophrenia: An analysis in a naturalistic setting. Compr Psychiatry 2009;50:200–8.
- De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort. Schizophr Res 2007;92:68–73.
- Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: Is functional remission a viable concept? Schizophr Bull 2009;35:300–6.
- Lindström E, Koernig T, Tuninger E, Levander S. Development and validation of the Fast Assessment in Acute Treatment of Psychosis—Observation Rating Scale (FAST-O). Int J Psychiat Clin Pract 2011; in press.
- Novick D, Haro JM, Suarez D, Vieta E, Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophr Res 2009;108:223–30.
- De Hert MA, Simon V, Vidovic D, Franic T, Wampers M, Peuskens J, . Evaluation of the association between insight and symptoms in a large sample of patients with schizophrenia. Eur Psychiatry 2009;24:507–12.